asia-pacific – Asia Tab

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

September 2, 2022

SYDNEY, Sep 2, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in the Asia Pacific Region". The report was prepared by GlobalData and confirms that "the Asia-Pacific (APAC) region was the largest contributor to the global clinical trial landscape from 2017 to 2021, accounting for more than 50% of conducted trials during the analysis period."Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData research found that all phases of clinical trials in the region registered higher growth than both the US and the EU5.The region registered significantly higher growth than the US and the EU5 across all analysed therapeutic areas, including CNS diseases, cardiovascular diseases, gastrointestinal diseases, and infectious diseases, the latter of which witnessed the highest growth. There was also 100% growth in oncology trials during the same period.GlobalData analysis of this strong growth has been linked to a range of factors, including:- site availability, particularly for oncology trials, when compared to the US and Europe- lower operating costs- the pharmacogenomic profile of Asian populations as a key factor that requires Phase I data in local populations. "Add to the mix the ease of regulatory compliance as well as the high standards required, and overseas drugmakers have never been keener to access this burgeoning market," according to GlobalData. "Recent streamlining of drug approval by the government, guided by the National Health Commission (NHC) and National Medical Products Administration (NMPA), has also resulted in a more efficient and clear-cut drug approval system based on global standards."According to Yooni Kim, Vice President, Global Clinical Services Novotech: "Asia-Pacific offers a compelling solution for expedited clinical trials with its vast patient populations, less competitive clinical trial landscape, and world-class KOLs, in addition, regulatory reforms have accelerated approval processes. Novotech's service delivery model is tailored to the needs of biotech clients. Our local teams have exceptional site and investigator access, our project management approach emphasizes problem-solving, ownership and flexibility, and our investments in data and technology ensure clients have real-time access to trial performance. In addition, experienced CRO operations across APAC and the US offer a unique and unparalleled suite of services for early to late phase biotech clinical research."Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs, and has signed 45 Leading Site Partnership agreements over the last 3 years. About Novotech Novotech is the leading Asia-Pacific biotech specialist CRO. Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases. It has been instrumental in the success of approximately 4,000 clinical trials across a broad range of therapeutic areas. Novotech is well-positioned to serve biopharma clients conducting clinical trials in Asia-Pacific and the US. For more information visit https://novotech-cro.com/contactMedia ContactDavid JamesE: communications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)

Asia-Pacific housing stakeholders’ call to ‘build forward better’ continues at World Urban Forum, Poland

July 1, 2022

BANGKOK, Jul 1, 2022 - (ACN Newswire via SEAPRWire.com) - Key findings from the newly published Asia-Pacific Forum report will be brought to the global conversations on housing and shelter amid the impacts of climate change, and COVID-19 during the 11th World Urban Forum on June 26-30, 2022, at Katowice, Poland. "Building forward better through inclusive housing means that each one of us, especially the most vulnerable families we serve through housing solutions, has a voice in the process and a role to play in increasing access to a decent place to live," said Luis Noda, Habitat for Humanity's Asia-Pacific vice president and one of the speakers at the Asia-Pacific Housing Forum. "This core belief guides Habitat for Humanity as we lend our voices on WUF11 discussions on building resilience to a broad range of shocks and threats through an innovative and inclusive approach, thus working toward a sustainable and green future for our global community."WUF11's overall theme will be focusing on overcoming the multiple urban crises while transforming our cities for a better urban future. In alignment with WUF11 thematic objectives, the participants from the Asia-Pacific forum also focused on the shared responsibility and individual roles of the government, civil society, the private sector, academia, and the donor community in achieving appropriate housing for everyone. Forming partnerships and encouraging social participation and innovation that allow for a sustainable response to the housing problem are critical in strengthening resilience against other factors that compound the housing challenges of the region--the effects of climate change, inadequate national housing policies and programs, limited access to technologies, and lack of empowered communities. As Asia-Pacific continues to feel the long-term impact of COVID-19--UN estimates that 200 million people might be forced into extreme poverty by 2030 and the region is one of the most highly affected areas--the housing sector remains critical to the region's economic, social, and environmental recovery. Other WUF11 themes resonate with other critical issues that surfaced during the APHF, such as effective responses to the housing challenge can also drive urban development and should be equally concerned with the environment. Greening the housing value chain can help reduce costs and impacts in the short and long term. Thus, it requires a shift to sustainable methods on material production, design/manufacturing, usage, recycling, among others; and should be supported by access to information and technologies, capacity building, and resources. More than 900 housing stakeholders, including the public, private, and civil society sectors, from 53 locations have participated at the eighth Asia-Pacific Housing Forum held last December 7-9, 2021. The discussions above are summarized in the final report available at the APHF website, www.aphousingforum.org. About Habitat for HumanityDriven by the vision that everyone needs a decent place to live, Habitat for Humanity found its earliest inspirations as a grassroots movement on an interracial community farm in U.S.A. Since its founding in 1976, the housing organization has grown to become a leading global nonprofit working in more than 70 countries. In the Asia-Pacific region since 1983, Habitat for Humanity has supported millions of people to build or improve a place they can call home. Through financial support, volunteering or adding a voice to support affordable housing, everyone can help families achieve the strength, stability and self-reliance they need to build better lives for themselves. To learn more, donate or volunteer, visit habitat.org/asiapacific.Media contact: Maetavarin Maneekulpan+66-2260-5820mae@tqpr.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)